Compounds > 3-(n-maleimidopropionyl)biocytin
Page last updated: 2024-09-03

3-(n-maleimidopropionyl)biocytin and biotinyl-n-hydroxysulfosuccinimide ester

3-(n-maleimidopropionyl)biocytin has been researched along with biotinyl-n-hydroxysulfosuccinimide ester in 1 studies

Compound Research Comparison

Studies
(3-(n-maleimidopropionyl)biocytin)		Trials
(3-(n-maleimidopropionyl)biocytin)		Recent Studies (post-2010)
(3-(n-maleimidopropionyl)biocytin)		Studies
(biotinyl-n-hydroxysulfosuccinimide ester)		Trials
(biotinyl-n-hydroxysulfosuccinimide ester)		Recent Studies (post-2010) (biotinyl-n-hydroxysulfosuccinimide ester)
30151200

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donoghue, N; Hogg, PJ; Jiang, XM; Li, P; Matthias, LJ; Poumbourios, P; Vandegraaff, N; Yam, PT1

Other Studies

1 other study(ies) available for 3-(n-maleimidopropionyl)biocytin and biotinyl-n-hydroxysulfosuccinimide ester

ArticleYear
Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.
    Nature immunology, 2002, Volume: 3, Issue:8

    Topics: Arsenicals; Biotin; CD4 Antigens; CD4-Positive T-Lymphocytes; Cysteine; Glutathione; HIV-1; Humans; Immunoblotting; Lysine; Maleimides; Mutation; Oxidation-Reduction; Protein Structure, Tertiary; Receptors, HIV; Succinimides; Sulfhydryl Compounds; Thioredoxins

2002